ObsEva competitorsClear all

ObsEva's top competitors include BTG, Zogenix, Clinigen Group and Durect.
ObsEva
ObsEva
ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.
BTG
BTG
BTG is an international specialist healthcare company.
Zogenix
Zogenix
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
Clinigen Group
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Durect
Durect
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
Founding Date
Founding Date
2012
Founding Date
1948
Founding Date
2006
Founding Date
2010
Founding Date
N/A
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Plan-les-Ouates, CH HQ
Locations
London, GB HQ
Rosedale, AU
Ottawa, CA
Düsseldorf, DE
Hong Kong , HK
Ataşehir, TR
Ffostrasol, GB
see more
Locations
Emeryville, US HQ
Windsor And Maidenhead, GB
Locations
Burton upon Trent, GB HQ
Warriewood, AU
Chuo City, JP
Auckland, NZ
Singapore, SG
Pretoria, ZA
Weybridge, GB
see more
Locations
Cupertino, US HQ
Employees
Employees
522% decrease
Employees
N/A
Employees
9032% increase
Employees
465200% increase
Employees
885% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.7 b
Valuation ($)
1.8 b
Valuation ($)
86.6 m
Twitter followers
Twitter followers
N/A
Twitter followers
1.1 k
Twitter followers
517
Twitter followers
1.3 k
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
681901
Alexa Website Rank
1054241
Alexa Website Rank
314146
Alexa Website Rank
260657
Alexa Website Rank
138208

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
£731.3m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
£339.6m (FY, 2018)
Revenue (est.)
$18.6m (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
£221m (FY, 2019)
Cost of goods
N/A
Cost of goods
£216.1m (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
£510.3m (FY, 2019)
Gross profit
N/A
Gross profit
£123.6m (FY, 2018)
Gross profit
N/A
Net income
Net income
N/A
Net income
£88.3m (FY, 2019)
Net income
($123.9m) (FY, 2018)
Net income
£24.4m (FY, 2018)
Net income
($25.3m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 92.9m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 20m
For sources of this data, please see the company profile

View company profiles

BTG
HQ
London, GB

BTG is an international specialist healthcare company.

View company
Zogenix
HQ
Emeryville, US
Employees
90↑ 32% increase

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.

View company
Clinigen Group
HQ
Burton upon Trent, GB
Employees
465

A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time

View company
Durect
HQ
Cupertino, US
Employees
88↓ 5% decrease

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.

View company